Investors

What's New

Lupin Appoints Spiro Gavaris as President of U.S. Generics Business

Press Release

December 8, 2022

Lupin Launches Rufinamide Tablets USP in the United States

Press Release

December 5, 2022

Lupin Launches Formoterol Fumarate Inhalation Solution in the United States

Press Release

November 29, 2022

Lupin’s Brazilian Subsidiary, MedQuimica Acquires Rights to Nine Brands from Bausch Health

Press Release

November 28, 2022

Lupin Signs MoU with the Government of Rajasthan to strengthen Healthcare system

Press Release

November 21, 2022

Luforbec® 200/6 (beclometasone 200mcg / formoterol 6mcg) a certified carbon neutral inhaler is launched in the UK for the treatment of adult asthma1,2,3

Press Release

November 14, 2022

Lupin Q2 FY2023 Results

Press Release

November 9, 2022

Lupin Receives Tentative Approval from U.S. FDA for Drospirenone Tablets

Press Release

November 4, 2022

Lupin Launches Paliperidone Extended-Release Tablets in the United States

Press Release

October 20, 2022

Lupin Signs Agreement to Acquire Two Inhalation Brands from Sunovion

Press Release

October 20, 2022

Lupin Partners with Global Agencies to Increase Patient Access to Tuberculosis Prevention Treatment

Press Release

October 7, 2022

Lupin Appoints Dr. Shahin Fesharaki as Global Chief Scientific Officer

Press Release

October 7, 2022

Lupin Receives Approval from U.S. FDA for Darunavir Tablets

Press Release

October 4, 2022

Lupin Life announces association with Vikram Vedha as official energy partner with its Be One health and wellness supplement

Press Release

October 1, 2022

Lupin gets EIR from US FDA for its Ankleshwar Manufacturing Facility

Press Release

October 1, 2022

Lupin Receives Approval from U.S. FDA for Mirabegron Extended-Release Tablets

Press Release

September 29, 2022

Lupin Launches Sildenafil for Oral Suspension in the United States

Press Release

September 29, 2022

Lupin Receives Approval from U.S. FDA for Diclofenac Sodium Topical Solution USP, 2% w/w

Press Release

September 22, 2022

Lupin Receives Health Canada Approval for Rymti® (biosimilar Etanercept)

Press Release

September 13, 2022

Lupin Q1 FY2023 Results

Press Release

August 3, 2022

Lupin Receives Approval from U.S. FDA for Azilsartan Medoxomil Tablets

Press Release

July 25, 2022

Lupin Launches Authorized Generic Version of PENNSAID® 2% w/w in the United States

Press Release

December 9, 2022

Reports & Filings

Integrated Report 2022

Visit Microsite Download Now View all

Q2 FY 2023

Gross Profit : INR 23,784 mn
Gross profit margin : 58.1%
Investment in R&D : INR 3,376 mn

Download Results View all Results

Exchange filings (BSE/NSE)

View all

Corporate Governance

Committees of the Board

Code of Conduct

Policies

Shareholder Information

News and Events

Press Release

Lupin Quarter I FY2023 Results

Explore

Annual General Meeting

The 40th Annual General Meeting to be held on 3^rd August 2022 at 4 pm through Video Conferencing

Explore

Investor Contacts

Shareholder Services

investorservices@lupin.com
Investor Relations

hemantbakhru@lupin.com

Cookie	Duration	Description
ARRAffinity	6 months	This cookie is set by websites that run on Windows Azure cloud platform. The cookie is used to affinitize a client to an instance of an Azure Web App.
cookielawinfo-checkbox-advertisement	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	6 months	These cookies are set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-functional	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	6 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Other".
cookielawinfo-checkbox-performance	6 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	6 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	1 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_139647988_1	1 minute	These cookies are set by Google Analytics which is a simple tool that helps us measure how users interact with our website. As a user navigates between web pages, Google Analytics records information about the page a user has visited, for example the URL of the page. The cookies themselves are used to 'remember' what a user has done on previous pages and interactions with our website.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Duration	Description
IDE	1 year	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.

Cookie	Duration	Description
ARRAffinitySameSite	session	No description
CONSENT	6 months	No description

Investors

What's New

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Press Release

Reports & Filings

Integrated Report 2022

Q2 FY 2023

Exchange filings (BSE/NSE)

Corporate Governance

Shareholder Information

News and Events

Press Release

Annual General Meeting

Investor Contacts

Shareholder Services

Investor Relations

Subscribe for Investor updates

Cart